Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The cancelled 2015 Phase I trial (NCT02637284) was almost certainly abandoned for this reason rather than buried by a regulator
National Institute of Neurological Disorders and Stroke (NINDS) - Authoritative resource on traumatic brain injury, stroke, neurodegenerative diseases, and the neuroscience of brain repair mechanisms
The trade-off: tesamorelin gives you a precision tool for one specific problem
No formal contraindications derived from human data exist because human safety trials have not been completed
US$ 25.06
US$ 22.25
US$ 23.94
US$ 22.72
US$ 22.68
US$ 21.51
US$ 24.49
US$ 20.53
US$ 23.84
US$ 28.49
